GIANNOTTA, CLAUDIA

GIANNOTTA, CLAUDIA  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment 2024 Picca, Francesca; Giannotta, Claudia; Tao, Jiahao; Giordanengo, Lucia; Munir, H M Waqas; Botta, Virginia; Merlini, Alessandra; Mogavero, Andrea; Garbo, Edoardo; Poletto, Stefano; Bironzo, Paolo; Doronzo, Gabriella; Novello, Silvia; Taulli, Riccardo; Bersani, Francesca
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 2024 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status 2022 Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA 2022 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT 2020 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
MULTIFACETED IMMUNE CHECKPOINT EXPRESSION AND SENESCENT MARKERS IMPAIRS BONE MARROW Vγ9Vδ2 T-CELL FUNCTION IN MULTIPLE MYELOMA PATIENTS 2018 B Castella, C Riganti, M Foglietta, E Tripoli, C Giannotta, M Massaia
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells 2023 Giannotta, Claudia; Autino, Federica; Massaia, Massimo
Untangling the immune suppressive network to accelerate the roadmap for a cure in human myeloma 2023 -
Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? 2023 Giannotta, Claudia; Autino, Federica; Massaia, Massimo